Navigation Links
Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
Date:2/4/2010

DURHAM, N.C., Feb. 4 /PRNewswire/ -- Gorbec Pharmaceutical Services, a rapidly expanding contract developer and manufacturer of prescription pharmaceutical products, is opening a GMP-compliant analytical laboratory in Yantai, China.  This new facility will expand Gorbec's current services for analytical method development and testing.  Gorbec is taking this action to better serve its U.S. customer base as well as develop a presence in the emerging Asian market.

Gorbec currently provides complete development, regulatory, analytical, and manufacturing services for U.S.-based customers.  Gorbec's future plans call for an increased capacity to develop and submit New Drug Applications (NDA'S) and will require an expansion of analytical services.  In an effort to improve efficiencies and reduce costs, the company has elected to locate the new analytical facility in China.  The company's core business services, current analytical laboratory, and commercial manufacturing will remain in the U.S.  The China facility is expected to open May 1st, 2010 but Gorbec is already working with customers who have plans to use some of the new facility's capacity.

The Yanti facility will operate under the direction of Gorbec's Vice President of Analytical Chemistry, Dr. Jing Chen.  Dr. Chen received her PhD from Stanford University and brings a wealth of pharmaceutical experience to the operation.  She joined Gorbec after holding various positions at Genentech Inc. and Alza Corporation.  Working with Dr. Chen will be Yan Zhang who will oversee the daily operations locally in Yantai.

Gorbec's Founder and CEO, Mike Gorman added, "We are very excited about our future and our ability to offer a GMP laboratory in China.  This new location will allow us to serve our own needs as well as the needs of companies looking to develop and distribute pharmaceutical products for the Asian Market."

About Gorbec

Gorbec Pharmaceutical Services, Inc. is a privately held company providing complete pharmaceutical development and manufacturing services.  Gorbec's highly experienced management team has driven the company to become a leader in the field of cGMP contract manufacturing services.  The company is focused primarily on the development of new drugs products that fill specialty niches within the traditional segment of the pharmaceutical business.

SOURCE Gorbec Pharmaceutical Services, Inc.

RELATED LINKS
http://www.gorbec.com

'/>"/>

SOURCE Gorbec Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
2. Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
3. Americas Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti; More Help Coming
4. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
5. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
6. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
7. Americas Pharmaceutical Research Companies Donate $25 Million to Relief Efforts in Haiti; More Help Coming
8. Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing
9. New Research from Best Practices Can Save Biopharma Companies Millions: Pharmaceutical New Product Planning - Structure and Activities to Drive Profitability
10. Ophthalmic Pharmaceutical Drugs - A Global Market Perspective
11. Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination With Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016 AAIPharma Services Corp./Cambridge Major Laboratories, ... and development services for the pharmaceutical and biotechnology ... capacity in its Charleston, SC ... several recent investments. Charleston ... line with small-scale lyophilization. The site has invested ...
(Date:2/11/2016)... ANKENY, Iowa , 11 de fevereiro de ... a inauguração de sua fábrica de soroalbumina bovina ... Nova Zelândia. A fábrica fica na Ilha Norte ... Loop "), desenvolvido e estabelecido na fábrica da ... Iowa . O projeto e instalação dos ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets ... (APAC) breast cancer market will experience considerable expansion ... at a Compound Annual Growth Rate (CAGR) of 8.5%. ... - states that the Asia-Pacific ... billion in 2014 to $3.4 billion by 2021, at a ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... TX (PRWEB) , ... February 12, 2016 , ... ... of southwest Houston and surrounding communities by continuing it’s commitment to act as ... Family Promise. The organization works closely with area homeless families to fulfill immediate ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will ... access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi ...
(Date:2/12/2016)... ... February 12, 2016 , ... A lot has been ... years. A president has access to health and wellness resources most Americans could ever ... no single individual has a schedule as frenetic as the U.S. President. , ...
(Date:2/12/2016)... ... February 12, 2016 , ... The aging population ... of long term care. With that, says Patrick Loughney, president of Longtree ... roles in long term care environments. His company, which offers prep courses and ...
Breaking Medicine News(10 mins):